Drug recall · August 27, 2014
CYTARAbine for Injection USP recall
Why: Lack of Assurance of Sterility: Crimp defects during visual inspection could affect container closure integrity.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
CYTARAbine for Injection USP, lyophiled in glass vials, 1 gram per vial, Rx only, Distributed by Bedford Laboratories, Bedford, OH 44146, Manufactured by Ben Venue Labs, Inc., Bedford, OH 44146, NDC 55390-808-01
- Lots / codes
Lot # 0161-13-2167551; Exp. 07/14 Lot # 0161-13-2176919; Exp. 08/14
- Quantity
- 7172 vials
- Company
- Ben Venue Laboratories Inc, Bedford, OH
- Distribution
- Nationwide
- Initiated
- July 31, 2014 · Voluntary: Firm initiated
- Classified
- August 18, 2014
- Reported
- August 27, 2014
- Ended
- December 2, 2014
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Cytarabine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.